Home > News > Rexahn, university partner for drug development
March 4th, 2006
Rexahn, university partner for drug development
Abstract:
The University of Maryland has teamed with Rexahn Pharmaceuticals to improve the company's drugs that treat cancer and central nervous system disorders. Researchers from the university's Center for Nanomedicine and Cellular Delivery in Baltimore will work with Rockville-based Rexahn to find new ways of applying nanotechnology research to make more effective drugs.
Source:
ACBJ
Related Links |
Center for Nanomedicine and Cellular Delivery
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||